MARKET

GENFF

GENFF

Genflow Biosciences
OTCMQB
0.030
NaN%
Closed 09:30 02/12 EST
OPEN
--
PREV CLOSE
0.030
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.065
52 WEEK LOW
0.010
MARKET CAP
14.81M
P/E (TTM)
-4.4776
1D
5D
1M
3M
1Y
5Y
1D
Genflow Biosciences Reports Positive Interim Results for SIRT6 Gene Therapy in Aged Dogs
Reuters · 1d ago
Genflow Biosciences Proposes Share Issuance and Pre-emption Rights Disapplication for Potential Equity Raise at Upcoming General Meeting
Reuters · 2d ago
Genflow Biosciences Receives €4 Million Funding Approval from Wallonia Region
Reuters · 01/28 07:00
Genflow Biosciences Completes Dosing in Canine Gene Therapy Trial with No Adverse Events
Reuters · 12/16/2025 07:00
Genflow Biosciences to Attend J.P. Morgan Healthcare Conference
Reuters · 12/11/2025 07:01
Genflow Biosciences Announces Updated Total Issued Shares and Voting Rights
Reuters · 10/31/2025 07:00
Genflow Biosciences announces second European patent application
Seeking Alpha · 10/22/2025 06:57
Genflow Biosciences Publishes European Patent Application for SIRT6 Variant Targeting NASH
Reuters · 10/22/2025 06:00
More
About GENFF
Genflow Biosciences Plc is a United Kingdom-based biotechnology company. The Company is engaged in developing gene therapies designed to target the aging process and to reduce and delay the incidence of age-related diseases, which is done through therapeutics targeting aging in humans by using adeno-associated virus (AAV) vectors to deliver copies of the Sirtuin-6 (SIRT6) gene variant that is found in centenarians into cells. The Company's product pipeline includes GF-1002, GF-1003, GF-1004, GF-1005 and GF-1006. GF-4001. GF-1002 is a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. GF-1004 is a non-human version of GF-1002 anti-ageing gene therapy developed for veterinary use (dogs). GF-1003 is a formulation of an adeno-associated viral vector-based gene therapy. The Company has operations in the United Kingdom and Belgium.

Webull offers Genflow Biosciences PLC stock information, including OTCMQB: GENFF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GENFF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GENFF stock methods without spending real money on the virtual paper trading platform.